SML4292

SAF312

≥98% (HPLC), powder, TRPV1 antagonist

• Synonim(y): 4-[7-Hydroxy-2-(1-methylethyl)-4-oxo-3(4H)-quinazolinyl]benzonitrile, 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)benzonitril, Libvatrep, Vanilloid receptor antagonist 1
• Wzór empiryczny (zapis Hilla): C₁₈H₁₅N₃O₂
• Numer CAS: 871814-52-7
• Masa cząsteczkowa: 305.33
• NACRES: NA.21
• MDL number: MFCD18711490
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C

Opis

General description

SAF312 (Libvatrep), a quinazolinone derivative, is a potent and highly selective noncompetitive antagonist TRPV1 (transient receptor potential vanilloid 1) (IC50 = 14 nM).

Application

SAF312 may be used to evaluate the effects of its inhibitory action in CHO cells expressing human TRPV1.

Biochem/physiol Actions

SAF312 is a non-narcotic analgesic that is currently investigated as a treatment for ocular surface pain. SAF312 binds to the vanilloid binding pocket of TRPV1, which is located between the S3 and S4 helices of one subunit and the S5 and S6 domains of the adjacent subunit. This binding prevents crucial conformational changes in the S4 and S5 helices that are essential for channel gating.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS07
• Słowo ostrzegawcze: Warning
• Kody zagrożeń: H302,H315,H319
• Ostrzeżenia: P264 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P332 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
• Klasa składowania: 11 - Combustible Solids
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable